Viking Therapeutics (VKTX) Reports Q2 Loss of $0.22/Share

Go back to Viking Therapeutics (VKTX) Reports Q2 Loss of $0.22/Share
ING Van Kampen Equity Growth Fund S 2 Class (NASDAQ: VKTX) Delayed: 33.19 --0 (-0%)
Previous Close $33.19    52 Week High $5.17 
Open $33.19    52 Week Low $0.94 
Day High $33.19    P/E N/A 
Day Low $33.19    EPS $0.00 
Volume 2,825